T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial (Q41546170)

3 October 2017

T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial (English)

1 reference

3 October 2017

1 reference

1 reference

4

0 references

Cornelius J Clancy

2

object named as

Cornelius J Clancy

1 reference

3 October 2017

Dimitrios P Kontoyiannis

13

object named as

Dimitrios P Kontoyiannis

1 reference

3 October 2017

Luis L Ostrosky-Zeichner

3

object named as

Luis Ostrosky-Zeichner

1 reference

3 October 2017

14

Peter G Pappas

1 reference

3 October 2017

Eleftherios Mylonakis

1

1 reference

3 October 2017

Kevin W Garey

4

1 reference

3 October 2017

George J Alangaden

5

1 reference

3 October 2017

Jose A Vazquez

6

1 reference

3 October 2017

Jeffrey S Groeger

7

1 reference

3 October 2017

Marc A Judson

8

1 reference

3 October 2017

Yuka-Marie Vinagre

9

1 reference

3 October 2017

Stephen O Heard

10

1 reference

3 October 2017

Fainareti N Zervou

11

1 reference

3 October 2017

Ioannis M Zacharioudakis

12

1 reference

3 October 2017

language of work or name

English

0 references

publication date

12 January 2015

1 reference

Clinical Infectious Diseases

3 October 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 October 2017

60

1 reference

3 October 2017

892-899

1 reference

3 October 2017

6

1 reference

Multistate point-prevalence survey of health care-associated infections

3 October 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Septic shock attributed to Candida infection: importance of empiric therapy and source control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Molecular and nonmolecular diagnostic methods for invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

PCR diagnosis of invasive candidiasis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Risk factors for fluconazole-resistant candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Invasive mycoses: strategies for effective management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Opportunistic fungi: a view to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Emerging opportunistic yeast infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Time to positivity of blood cultures of different Candida species causing fungaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Global trends in the distribution of Candida species causing candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geogr

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Mixed fungemia: incidence, risk factors, and mortality in a general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Detection of Simulated Candidemia by the BACTEC 9240 System with Plus Aerobic/F and Anaerobic/F Blood Culture Bottles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for candida growth detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Comparison of BD Bactec Plus Aerobic/F medium to VersaTREK Redox 1 blood culture medium for detection of Candida spp. in seeded blood culture specimens containing therapeutic levels of antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Detection of fifteen species of Candida in an automated blood culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU959

21 January 2018

Identifiers

DOI

10.1093/CID/CIU959

1 reference

3 October 2017

1 reference